Valid

YY/T 0616.7-2020Medical gloves for single use - Part 7: Test method for the immunological measurement of antigenic protein (English PDF)

一次性使用医用手套 第7部分:抗原性蛋白质含量免疫学测定方法

Preview PDF

This is a limited preview

Buy now to download the full PDF (18 pages)

Need quotation for your management?

Get a formal quotation for YY/T 0616.7-2020 in 30 minutes.

Issued by

NMPA

Level / Type

Industry · Recommended

Issue date

September 27, 2020

Implementation date

September 1, 2021

Scope

YY/T 0616.7-2020 is the English-translated version of 一次性使用医用手套 第7部分:抗原性蛋白质含量免疫学测定方法.

YY/T 0616.7-2020 is the Chinese pharmaceutical industry standard that gives the immunological method for determining the antigenic protein content of single-use medical natural rubber latex gloves, the proteins responsible for latex allergy.

It is the seventh part of the YY/T 0616 series and sets out the principle of the determination, the instruments, the reagents and consumables, the extraction and measurement procedure and the content of the test report, so that the figure a manufacturer declares can be verified. Issued on 27 September 2020, it has applied since 1 September 2021.

Found what you need?

Document preview — YY/T 0616.7-2020

National Standard of the People's Republic of China

ICS
11.140.01
Classification
C 30

Issued by: National Medical Products Administration of the People's Republic of China

Contents

  • Foreword
  • Introduction
  • 1 Scope
  • 2 Normative references
  • 4 Abbreviations
  • 5 Test principle
  • 6 Instruments
  • 7 Reagents and consumables
  • 8 Measurement method

Foreword

The general title of YY/T 0616 is "Disposable Medical Gloves", which consists of the following parts.

---Part 1: Biological evaluation requirements and tests;

---Part 2: Requirements and tests for determining shelf life;

---Part 3: The method of determining the actual time expiration date with the finished gloves in the warehouse;

---Part 4: Test method for puncture resistance;

---Part 5: Test method for resistance to chemical penetration and continuous exposure;

---Part 6: Test method for evaluating penetration performance of anti-chemotherapeutic drugs;

---Part 7: Immunological determination method of antigenic protein content; This part is part 7 of YY/T 0616.

This section was drafted in accordance with the rules given in GB/T 1.1-2009.

Introduction

Medical staff may be exposed to some chemicals that are harmful to healthy people at work. To avoid such hazards, medical staff need to Wear products with corresponding protective properties (such as medical gloves) to achieve effective protection. Medical rubber gloves are made of raw materials The difference is usually divided into two categories. natural latex gloves and synthetic rubber gloves. Natural latex gloves contain natural latex protein, which can induce type I Hypersensitivity reactions, manifested as local skin urticaria, allergic rhinoconjunctivitis and asthma and other symptoms. There are many types of products derived from natural rubber latex A protein that can trigger (type I) allergic reactions. Due to the interference of chemical additives in natural rubber latex gloves, according to GB/T 21870-2008 Quantifying protein levels in natural rubber latex products may produce false positive results. In addition, the protein content of natural rubber latex in the product is often low The detection limit of standard colorimetric protein analysis.

1 Scope

This part of YY/T 0616 specifies the immunological determination of the antigenic protein content in disposable medical natural rubber latex gloves Test principles, instruments, reagents and consumables, measurement methods and test reports.

This section applies to the quantitative determination of antigenic protein content in disposable medical natural rubber latex gloves.

2 Normative references

The following documents are indispensable for the application of this document. For dated reference documents, only the dated version applies to this document. For undated reference documents, the latest version (including all amendments) is applicable to this document.

GB/T 16886.1 Biological Evaluation of Medical Devices Part 1: Evaluation and Testing in the Process of Risk Management

GB/T 16886.20 Biological Evaluation of Medical Devices Part 20: Principles and Methods of Immunotoxicology Tests for Medical Devices

4 Abbreviations

The following abbreviations apply to this document.

5 Test principle

This part is an immunological method that uses natural rubber latex (NRL) protein-specific antibodies to determine the content of antigen protein in natural rubber latex gloves.

The test sample and the specific antibody specific to the NRL protein are incubated together. Separate the remaining NRL protein antibody and combine it with the pre-coated The excess NRL protein antigen on the solid phase carrier is bound, and the substrate is added to develop the color. The color change is caused by the color reaction of the substrate, and the OD value is determined.

6 Instruments

And optional computer for data analysis).

7 Reagents and consumables

7.1 Reagents

7.1.1 Buffer
7.1.1.1 Carbonate buffer

Weigh with a balance and combine 0.795g sodium carbonate (Na2CO3), 1.465g sodium bicarbonate (NaHCO3), and 0.100g sodium azide (NaN3) is dissolved in distilled water and the volume is set to 500mL. Check the pH and adjust if necessary.

Note. The carbonate buffer can be stored at (4 ± 3) °C for at least 1 month.

7.1.1.2 PBS buffer

Use a balance to weigh 5.125g sodium dihydrogen phosphate (NaH2PO4·H2O), 45,000g disodium hydrogen phosphate (Na2HPO4·7H2O) and Dissolve in 1.5L distilled water and adjust the pH to 7.4. Add 175.3g of sodium chloride (NaCl) and dilute to 2L, which is 10 times the stock solution.

Use distilled water to dilute the 10-fold stock solution to PBS working solution before use.

7.1.1.3 T-PBS washing solution

Add 0.5mL Tween 20 (Tween 20) to 1LPBS working solution and mix well.

7.1.2 Blocking solution and antibody diluent
7.1.2.1 Sealing fluid

T-PBS containing 3g/mL skimmed milk powder, 100mL (used for the sealing treatment of the measuring plate and the dilution plate).

7.1.2.2 Diluent

T-PBS with 0.2g/mL skimmed milk powder, 100mL (used for blocking in antibody dilution and competitive inhibition steps).

7.1.3 Reference reagents

A NRL protein solution with a concentration of 1 mg/mL prepared with distilled water. The polypropylene tube is stored in (-20±10)°C, after thawing Store at (4±3)°C.

Note. The commercially available StAg standard solution is optional for IRM-913.

7.1.3.2 Coating antigen

The StAg solution was formulated into a solution with a concentration of 3µg/mL with carbonate buffer, which was used to coat the assay plate.

7.1.3.3 Reference standard

The StAg solution was formulated into a solution with a concentration of 2µg/mL with the diluent for competitive inhibition. In order to reduce possible protein loss, all steps involving protein-containing solutions should be performed in polypropylene tubes or containers. Avoid using polystyrene or glass containers.

7.1.4 Antibodies
7.1.4.1 Primary antibody

The commercially available anti-NRL antibody IRM-914 can be used.

7.1.4.2 Secondary antibodies

Horseradish peroxidase (HRP)-conjugated anti-rabbit IgG is used to detect the primary antibody bound to NRL protein on the solid phase. Recommended diluent Dilute 1.5 and store in aliquots at (-20±10)°C.

7.1.5 Substrate color developing solution

O-phenylenediamine (OPD) and hydrogen peroxide (H2O2) can be used for yellow color reaction. Dissolve commercially available OPD tablets in distilled water, And add an appropriate amount of H2O2 according to the operating instructions. For example, dissolve 10mgOPD tablets in 10ml distilled water and add it before use 30µL30% H2O2.

Note. TMB kit can also be used for color development.

7.2 Consumables

96-well microassay plate; dilution plate, 96-well plate with low protein binding for sample dilution and antibody reaction; multi-channel pipette; ELISA Plate sealing tape or plastic cover.

8 Measurement method

8.1 Sample preparation

8.1.1 It is advisable to use the PBS working solution of 7.1.1.2 as the extract.

8.1.2 Weigh the natural rubber latex gloves, and record the mass and surface area; 5 mL of extraction medium should be added to each gram of natural rubber latex gloves. Extraction temperature The temperature is (25 ± 5) °C; the extraction time is (120 ± 5) min. The extraction process should be agitated continuously to ensure that the sample is in full contact with the extraction medium.

Or oscillate 3 times at the beginning, middle and end stages of the extraction process, with an interval of 15s/time.

Filter the low-protein binding 0.45µm filter to collect the extract into a polypropylene tube.

Note 1.The extraction is carried out in a polypropylene container to reduce the possibility of protein loss due to adsorption to the inner surface of the container wall.

Note 2.Generally, the obtained extract can be used immediately, but it can be stored at (4 ± 3) °C for up to 2 days.

8.2 Test procedure

8.2.1 Closure of the dilution plate

Add 300µL of blocking solution to each well of the 96-well dilution plate, and incubate overnight at (4±3)°C.

8.2.2 Coating of the measuring plate

Add 100µL of coating antigen (StAg, 3µg/mL) to each well of the 96-well assay plate, and seal the plate with ELISA plate sealing tape or plastic lid.

Incubate at (37±1)°C for (120±5)min. Wash the plate once with T-PBS and discard the supernatant. Or coat the antigen at (4±3)°C overnight, and in the follow-up T-PBS washes the plate once before the start of the test. Add 300µL of blocking solution to each well and seal the plate, and incubate at (37±1)°C in a thermostat for 1h.

8.2.3 Inhibition steps

8.2.3.1 In the 96-well dilution plate, wash the plate twice with T-PBS; as shown in Table 1, except for row A, add 100µL of dilution buffer to each well; add wells A1 and A2 to row A Add.200 µL of antigen standard (StAg, 2 µg/mL) to each well, and add.200 µL of test sample to wells A3 to A12 (at least 2 replicate wells for each sample); by taking 100 µL/well from row A to each well of row B, and then Sequentially from row B to row G, perform 7 serial dilutions of the antigen standard or sample to be tested (mix by pipetting up and down 5 times each time, and finally discard it after mixing in row G)

100µL/well); H behavior has no inhibition, and each well contains 100µL diluent.

Note. Each sample to be tested has 3 dilution multiples (at least 2 dilution multiples), and each 1 dilution multiple has 2 replicates.

8.2.3.2 Prepare an appropriate dilution of the primary antibody so that the maximum OD value of the "uninhibited" well is 0.8 to 2.0. According to Table 1, add the primary antibody 100µL/hole, none...

......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 18 pages — is available in the English PDF.

Referenced standards

Similar standards

How to Download YY/T 0616.7-2020

  1. 1

    Add to cart

    Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.

  2. 2

    Checkout

    Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).

  3. 3

    Instant delivery (0–9 sec)

    Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.

  4. 4

    Invoice included

    A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.

Related Standards

English PDF
18 pages
Instant delivery (0–9 sec)
Invoice included
View Cart

Secure payment via Stripe

Payments accepted

VisaMastercardAmerican ExpressApple PayGoogle PayStripe

YY/T 0616.7-2020

$150.00